Total Revenue

6% YoY [N/A]

Total Revenue increased by 6% to $2.8 billion, driven by a mix of solid digital and subscription performance across key regions such as the Americas (+8% YoY) and APAC (+10% YoY), which helped offset modest declines in hardware and EMEA revenue, reflecting an overall balanced growth strategy compared to previous periods [N/A].

Digital Solutions Business

12% YoY [N/A]

Digital Solutions Business revenue grew 12% to $1.5 billion, benefiting from increased demand for digital transformation and recurring revenue streams from innovative product offerings that built on prior period advancements and further consolidated the company’s position in digital markets [N/A].

Hardware Segment

-3% YoY [N/A]

The Hardware Segment declined by 3% to $900 million, likely reflecting a shift in customer preferences away from traditional hardware towards digital and cloud solutions, as well as potential operational challenges or market saturation that were less pronounced in previous periods [N/A].

Americas Revenue

+8% YoY [N/A]

Americas revenue reached $1.2 billion with an 8% increase, driven by mature market dynamics, effective client retention strategies, and consistent recurring revenues which built on historical strengths and investment in local sales and service initiatives compared to earlier periods [N/A].

EMEA Revenue

-2% YoY [N/A]

EMEA revenue declined by 2% to $800 million, suggesting that economic headwinds and intensified competition in this region have impacted performance, contrasting with more robust growth seen in other markets in the previous period [N/A].

APAC Revenue

+10% YoY [N/A]

APAC revenue grew by 10% to $600 million, reflecting accelerated market adoption and increased investments in digital and cloud technologies in emerging markets, which marks an improvement over the past period’s performance [N/A].

Cloud Services

+25% YoY [N/A]

Cloud Services saw dramatic momentum with a 25% increase to $400 million, driven by rapid client implementations, integration of new AI and automation capabilities, and a recession-resilient value proposition that built on earlier period trends of increasing reliance on cloud-based solutions [N/A].

Revenue Guidance

FY 2025

Range: $1.006B–$1.022B, Midpoint: $1.014B "

Range: $1.030B–$1.042B, Midpoint: $1.036B " "

raised

Adjusted EBITDA Guidance

FY 2025

Range: $406M–$414M, Midpoint: $410M "

Range: $418M–$426M, Midpoint: $422M "

raised

Exclusion of Iodine Acquisition Impact

FY 2025

no prior guidance

Excludes potential impact from pending Iodine Software acquisition "

no prior guidance

Strategic AI-Driven Expansion and Acquisitions

Prior quarters emphasized leveraging generative AI to drive innovation and noted a disciplined M&A approach with examples in Q1 2025 " " " and detailed discussions on AI integration and acquisition history in Q4 2024 and Q3 2024. " " " " "

Q2 2025 focused on the acquisition of Iodine Software with detailed discussion of strategic fit, cost synergies, acceleration of the product roadmap, and bidirectional cross-sell opportunities. " " " " " "

Increased emphasis on AI-driven expansion with a high-profile acquisition; the focus has shifted from general M&A activity to executing a strategic, technology-enabled growth play.

Generative AI and Operational Efficiency

Previous calls (Q1, Q4, Q3 2024) highlighted generative AI capabilities (e.g., AltitudeAI, Altitude Create) that improved approval rates, reduced manual processes, and advanced operational efficiency. " " " " " " "

Q2 2025 showcased Waystar Altitude AI delivering improved appeal productivity, faster processing, prevention of denied claims, and significant operational cost synergies, reinforcing AI’s role across the platform. " " "

Continued robust integration of generative AI with clearer, quantifiable benefits in operational efficiency and automation, further accelerating the product roadmap.

Client Retention and Cross-Sell/Upselling Strategies

Earlier periods (Q1, Q4, Q3 2024) stressed exceptional retention rates, high net revenue retention figures (109–114%), and proactive cross-sell/upsell efforts—especially from clients acquired post a competitor cyber event. " " " " " " "

Q2 2025 emphasized excellent retention among migrated clients, new cross-sell opportunities driven by the Iodine acquisition, and notable large client wins that continue to validate strong client relationships. " " " "

Consistent focus on high client retention with evolving strategies through acquisitions, reinforcing cross-sell initiatives as a long-term driver of growth.

Robust Pipeline and Revenue Growth

Previous discussions in Q1, Q4, and Q3 2024 reported double-digit revenue growth—from 14% to 22% YoY—and highlighted a robust and expanding pipeline driven by strong client acquisition and utilization. " " " " " "

Q2 2025 reported the fifth consecutive quarter of double-digit revenue growth with 15% YoY growth, strong bookings momentum, and a robust pipeline of opportunities validating efficient cash flow and market interest. " " " "

Sustained robust pipeline and revenue growth with a gradual stabilization as abnormal boosts from prior periods phase out.

Revenue Mix Sustainability (Volume-Based vs Recurring)

Prior periods (Q1, Q4, Q3 2024) consistently demonstrated a balanced revenue mix—with roughly 50% subscription and 50% volume-based revenue—and emphasized high recurrence through contracted solutions. " " " " "

Q2 2025 reaffirmed a balanced mix (around 50% each) with volume-based revenue growing 14% YoY and subscription revenue up 17% YoY, supported by predictable, locked-in contracting and utilization trends. " " "

Consistent and sustainable revenue mix persists with continued emphasis on recurring contracts; volume growth remains solid and contributes to overall strength.

Competitive Pressures and Customer Churn Risks

Earlier quarters (Q1, Q4, Q3 2024) noted strong client retention with high NRR, and highlighted increasing RFP activity and competitive positioning even amid competitor cyber events, with minimal churn risks reported. " " " " " " "

Q2 2025 acknowledged competitor efforts (e.g., reaching back to former clients) but maintained that excellent retention, strong client trust, and robust platform performance keep churn risks minimal. " "

Consistent competitive strength with minimal customer churn—competitor pressures are monitored, but robust retention and strong platform benefits mitigate these risks.

Macroeconomic and Policy Sensitivities

Q1 2025 discussed recession-resistance and the ability to adapt to policy changes, while Q4 2024 mentioned technology’s role amid policy shifts; Q3 2024 had no direct commentary. " " " "

Q2 2025 provided detailed analysis of a hypothetical Medicaid funding cut (15% reduction) and its minimal impact (<1% on revenue), reinforced by a diverse client base and resilience to policy changes. " " " "

An increased focus on scenario analysis and resilience—the company is proactively modeling policy changes and demonstrating its insulated, diversified business model.

Integration and Execution Risks

Q1 2025 mentioned a strong M&A record with disciplined integration processes, though Q4 and Q3 2024 did not address integration risks directly. "

Q2 2025 reiterated the proven M&A playbook with the Iodine acquisition’s clear synergy realization and seamless integration record, supporting confidence in execution. "

Continued positive sentiment regarding integration capabilities with minimal concerns, as execution risks remain well-managed.

Extended Sales Cycle and RFP Complexity

Q1 2025 and Q4 2024 noted robust RFP activity and the increasing complexity of large platform deals, while Q3 2024 provided detailed commentary on extended sales cycles and multi-stakeholder decision-making. " " "

Q2 2025 did not mention extended sales cycles or RFP complexity, suggesting this topic has receded from the current discussion [N/A].

Reduced emphasis in Q2 2025—suggesting that after previous heightened focus, sales cycles and RFP complexities have normalized or are less top-of-mind.

Normalization of Abnormal Growth Trends

Prior calls in Q1, Q4, and Q3 2024 highlighted abnormal growth boosts from rapid client onboarding post-cyber event and elevated patient utilization, with expectations set for normalization in 2025. " " " " "

Q2 2025 confirmed that the abnormal growth trends, largely driven by the one-time cyber event impact, have normalized, with growth now reflecting a balance between as-reported and normalized rate. "

Clear shift from abnormal, event-driven growth back to normalized, sustainable growth rates in 2025.

Patient Payment Volume and Credit Quality Concerns

Previous discussions across Q1, Q4, and Q3 2024 emphasized strong patient payment volumes with seasonal trends, high utilization, and no noted credit quality concerns. " " " " " "

Q2 2025 highlighted robust patient payment volume with high self-service adoption and significant revenue impact, while no credit quality concerns were raised. " " "

Consistent positive performance on patient payment volume; credit quality remains stable with no emerging concerns.

Decline of One-Time Competitor Cyber Event Impact

Earlier periods (Q1, Q4, Q3 2024) provided detailed insights into the immediate revenue boost from rapid client migration after the competitor cyberattack, and discussed the expectation of normalization in subsequent periods. " " " " " " " "

Q2 2025 stated that the direct revenue impact from the competitor cyber event has essentially lapsed, with the benefit from rapid onboarding now normalized, confirming the temporary nature of that boost. "

The impact of the competitor cyber event has declined as anticipated, with its effects diminishing in the year-over-year comparisons and revenue now reflecting normalized growth.